Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus
暂无分享,去创建一个
K. Shimada | M. Moriguchi | Saiyu Tanaka | Yuya Seko | K. Yamaguchi | Y. Itoh | T. Hara | Taichiro Nishikawa | Akira Okajima | A. Umemura | K. Kanemasa | Y. Sumida | Hiroyoshi Taketani | K. Yasui | Shunsuke Imai | Kojiroh Mori | H. Ishiba